← All trials
NCT04750083
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 25, 2020
- Primary completion
- Sep 25, 2022
- Completion date
- Sep 25, 2023
- First posted
- Feb 11, 2021
- Last posted
- Feb 11, 2021
- Enrollment
- 700
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Taizhou Hanzhong biomedical co. LTDLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.